Quantcast

Latest Ipratropium/salbutamol Stories

FDA To Phase Out Some Primatene Asthma Inhalers
2011-09-23 09:29:23

  An over-the-counter asthma inhaler is to be banned beginning next year because federal health officials said it produces carbon gas that is harmful to the environment, Reuters reports. The inhaler in question is currently the only over-the-counter inhaler on the market, which when banned, will leave asthma patients with only prescription-based choices. The Food and Drug Administration said on Thursday that chlorofluorocarbons (CFCs) in the metered-dose inhalers that contain...

2010-04-26 08:45:00

WALTHAM, Mass., April 26 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive...

2010-04-13 17:12:00

RIDGEFIELD, Conn., April 13 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling, COMBIVENT will remain on the market and available to the more than two million chronic obstructive pulmonary disease (COPD)...

2010-04-13 12:59:00

SILVER SPRING, Md., April 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move...

2010-03-18 10:11:00

PITTSBURGH, March 18 /PRNewswire/ -- ChemImage, a world leader in chemical imaging products and services, will present the results of an ingredient-specific particle sizing (ISPST) study on a combination Metered Dose Inhaler product at Respiratory Drug Delivery (RDD) 2010 (www.rddonline.com). This conference will take place from April 25th - 29th in Orlando, Florida and will feature thought leaders discussing current biological and pharmaceutical issues related to nasal and respiratory...

2009-09-17 15:53:00

NAPA, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Dey, L.P. today announced that it has settled a lawsuit brought against it and other companies by the State of Utah in October 2005 pertaining to Medicaid reimbursements paid by the state to pharmacists and other healthcare providers. In exchange for a full release of claims, Dey has agreed to pay approximately $1 million. As part of the 2007 acquisition agreement between Mylan Inc. (Dey's parent company) and Merck KGaA (Dey's former parent...

2009-09-17 16:01:54

Federal officials are warming consumers not to use certain respiratory medications purchased after Sept. 8, produced by Dey L.P., a subsidiary of Mylan Inc. The U.S. Food and Drug Administration said the medications might have been part of a shipment being transported on a tractor-trailer stolen in Tampa, Fla. The FDA said the respiratory medications -- Ipratropium Bromide Inhalation Solution, 0.02%, and Albuterol Sulfate Inhalation Solution, 0.083%, -- have not been recovered and might be...

2009-01-12 07:30:00

PITTSBURGH, Jan. 12 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Dey L.P. has been issued several additional U.S. patents protecting the company's Perforomist(R) Inhalation Solution, a chronic obstructive pulmonary disease (COPD) treatment. U.S. Patent No. 7,462,645 was issued Dec. 9, 2008, and is directed to treatment through the administration of a ready-to-use, storage stable composition of formoterol. This patent covers Dey's...

2009-01-07 10:03:00

NAPA, Calif., Jan. 7 /PRNewswire/ -- Dey, L.P. today announced that it has settled a lawsuit brought against it and other companies by the State of Mississippi in October 2005 pertaining to Medicaid reimbursements paid by the state to pharmacists and other healthcare providers. In exchange for a full release of claims, Dey has agreed to pay $3.8 million plus legal and other costs. As part of the 2007 acquisition agreement between Mylan Inc. (Dey's parent company) and Merck KGaA (Dey's former...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related